The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study

NCT05121571 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: HAIC
DRUG: Sorafenib

Sponsor

Sun Yat-sen University